Private Wealth Partners, LLC

Position in NVO — Novo Nordisk A S

CIK 1335851 MILL VALLEY, CA

Position in NVO

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$1,473,435

+$413,749 QoQ

Shares Held

30,735

+6.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#435

of 1,348 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Private Wealth Partners, LLC holds $114,747,737 across 10 Drug Manufacturers - General names. NVO ranks #6 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	301,750	$38,774,875
2	ABBV	AbbVie Inc.	136,981	$34,469,898
3	JNJ	Johnson & Johnson	71,949	$18,272,887
4	PFE	Pfizer Inc	619,840	$14,925,747
5	LLY	ELI LILLY & Co	4,448	$5,335,065
6	NVO	Novo Nordisk A S This page	30,735	$1,473,435
7	GILD	Gilead Sciences, Inc.	6,018	$760,314
8	BMY	Bristol Myers Squibb Co	5,300	$305,386

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,473,435	30,735	+6.6%	Shares	Sole	2026-08-03
2026-03-31	$1,059,686	28,835	+15.6%	Shares	Sole	2026-04-28
2025-12-31	$1,269,456	24,950	+15.3%	Shares	Sole	2026-01-27
2025-09-30	$1,200,692	21,638	-59.6%	Shares	Sole	2025-11-04
2025-06-30	$3,698,988	53,593	-18.6%	Shares	Sole	2025-08-01
2025-03-31	$4,573,318	65,860	+33.6%	Shares	Sole	2025-04-22
2024-12-31	$4,240,786	49,300	+48.5%	Shares	Sole	2025-02-03
2024-09-30	$3,953,481	33,203	+155.1%	Shares	Sole	2024-10-29
2024-06-30	$1,857,761	13,015	+71.9%	Shares	Sole	2024-08-08
2024-03-31	$971,988	7,570	+27.2%	Shares	Sole	2024-05-09
2023-12-31	$615,527	5,950	—	Shares	Sole	2024-02-02
No filing history on record for this holder in this stock.